01940nam a22004931i 4500 000709815 CaToSAGE 20240202172917.0 20180103162434.3 m|||||o||d|||||||| cr ||||||||||| 180103r20062006enka fo 000 0|eng|d NEZPRACOVANÝ IMPORT 9781526449818 (ebook) : No price (OCoLC)1023537886 CaToSAGE eng CaToSAGE rda pn UtOrBLW RM370 .D54 2006 615.37 23 Diermeier, Daniel, author. Reintroduce Thalidomide? (B) / Daniel Diermeier, Jason Hermitage, Shail Thaker, Justin Heinze. London : Kellogg School of Management, 2006. 1 online resource : illustrations. text txt rdacontent computer c rdamedia online resource cr rdacarrier SAGE Knowledge. Cases Originally published in Diermeier, D., Hermitage, J., Thaker, S., & Heinze, J. (2006). Reintroduce thalidomide? (B). 5-104-003(B). Evanston, IL: Kellogg School of Management at Northwestern University. The case explains how and why Thalidomide was at last licensed by the FDA and how this would benefit the manufacturer of the drug Celgene. Description based on XML content. elektronické knihy fd186907 czenas electronic books eczenas United States. Food and Drug Administration. Immunopharmacology. Thalidomide. Hermitage, Jason, author. Thaker, Shail, author. Heinze, Justin, author. SAGE Knowledge. Cases. SAGE Knowledge https://sk.sagepub.com/cases/reintroduce-thalidomide-b Plný text SBC EB NEPOSILAT EB